Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier(R) as a Treatment for Life-Threatening Viruses

SAN DIEGO, Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that it has received an Expedited Access ... Devices, FDA Aethlon Medical, Hemopurifier

Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news